This inventor holds 1 USPTO granted patent. Top assignee: Cumbre IP Ventures, L.p.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: A Simon Lynch: Innovator in Antibacterial Pharmaceutical Development
Introduction
A Simon Lynch is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. His innovative work focuses on creating effective treatments for bacterial diseases.
Latest Patents
Lynch holds a patent for "Nitroheteroaryl-containing rifamycin derivatives." This patent describes substituted rifamycin derivatives in which a nitroimidazole, nitrothiazole, or nitrofuran pharmacophore is covalently bonded to a rifamycin. The patent also discloses methods of using these rifamycin derivatives and pharmaceutical compositions containing them. The rifamycin derivatives possess antibacterial activity and are effective against various human and veterinary pathogens in the treatment of bacterial diseases.
Career Highlights
Lynch is associated with Cumbre IP Ventures, L.P., where he continues to advance his research and development efforts. His work has been instrumental in the creation of new pharmaceutical solutions that address pressing health challenges.
Collaborations
Some of his notable coworkers include Charles Z Ding and In Ho Kim. Their collaborative efforts contribute to the innovative environment at Cumbre IP Ventures, L.P.
Conclusion
A Simon Lynch's contributions to antibacterial pharmaceutical development highlight his role as a key innovator in the field. His patented work on rifamycin derivatives showcases the potential for new treatments against bacterial diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile